Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients

References

• BrownSKimMMitchellCInskipHTwenty-five year mortality of a community cohort with schizophreniaBr J Psychiatry2010196211612120118455
   PubMed Web of Science ®Google Scholar
• OlfsonMGerhardTHuangCCrystalSStroupTSPremature mortality among adults with schizophrenia in the United StatesJAMA Psychiatry201572121172118126509694
   PubMed Web of Science ®Google Scholar
• WalkerERMcgeeREDrussBGMortality in mental disorders and global disease burden implications: a systematic review and meta-analysisJAMA Psychiatry201572433434125671328
   PubMed Web of Science ®Google Scholar
• HealyDLe NouryJHarrisMMortality in schizophrenia and related psychoses: data from two cohorts, 1875–1924 and 1994–2010BMJ Open201225e001810
   Web of Science ®Google Scholar
• IfteniPCorrellCUBurteaVKaneJMManuPSudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatientsSchizophr Res20141551–3727624704220
   PubMed Web of Science ®Google Scholar
• KoponenHAlaräisänenASaariKSchizophrenia and sudden cardiac death: a reviewNord J Psychiatry200862534234518752109
   PubMed Web of Science ®Google Scholar
• ApplebyLThomasSFerrierNLewisGShawJAmosTSudden unexplained death in psychiatric in-patientsBr J Psychiatry200017640540610912212
   PubMed Web of Science ®Google Scholar
• MentonenOPArankoKMalkonenLVapaataloHA survey of 49 cases of sudden death associated with the use of antipsychotic or antidepressant drugsActa Psychiatr Scand199184158641681681
   PubMed Web of Science ®Google Scholar
• AgelinkMWMajewskiTWurthmannCEffects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapineJ Clin Psychopharmacol200121181311199953
   PubMed Web of Science ®Google Scholar
• BirkhoferAGeissendoerferJAlgerPThe deceleration capacity – a new measure of heart rate variability evaluated in patients with schizophrenia and antipsychotic treatmentEur Psychiatry2013282818621920708
   PubMed Web of Science ®Google Scholar
• CohenHLoewenthalUMatarMKotlerMAssociation of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medicationBr J Psychiatry2001179216717111483480
   PubMed Web of Science ®Google Scholar
• HuangWLChangLRKuoTBLinYHChenYZYangCCImpact of antipsychotics and anticholinergics on autonomic modulation in patients with schizophreniaJ Clin Psychopharmacol201333217017723422372
   PubMed Web of Science ®Google Scholar
• IedaMMiyaokaTWakeREvaluation of autonomic nervous system by salivary alpha-amylase level and heart rate variability in patients with schizophreniaEur Arch Psychiatry Clin Neurosci20142641838723645102
   PubMed Web of Science ®Google Scholar
• IwamotoYKawanishiCKishidaIDose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophreniaBMC Psychiatry20121219923151241
   PubMed Web of Science ®Google Scholar
• KimJHYiSHYooCSHeart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjectsProg Neuropsychopharmacol Biol Psychiatry200428237137814751435
   PubMed Web of Science ®Google Scholar
• ThayerJFYamamotoSSBrosschotJFThe relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factorsInt J Cardiol2010141212213119910061
   PubMed Web of Science ®Google Scholar
• LeuchtCHeresSKaneJMKisslingWDavisJMLeuchtSOral versus depot antipsychotic drugs for schizophrenia – a critical systematic review and meta-analysis of randomised long-term trialsSchizophr Res20111271–3839221257294
   PubMed Web of Science ®Google Scholar
• KishimotoTNittaMBorensteinMKaneJMCorrellCULong-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studiesJ Clin Psychiatry2013741095796524229745
   PubMed Web of Science ®Google Scholar
• KishimotoTRobenzadehALeuchtCLong-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trialsSchizophr Bull201440119221323256986
   PubMed Web of Science ®Google Scholar
• TaipaleHMehtäläJTanskanenATiihonenJComparative Effectiveness of antipsychotic drugs for rehospitalization in schizophrenia–a nationwide study with 20-year follow-upSchizophr Bull Epub2017122010.1093/schbul/sbx176
   Web of Science ®Google Scholar
• TiihonenJMittendorfer-RutzEMajakMReal-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophreniaJAMA Psychiatry201774768669328593216
   PubMed Web of Science ®Google Scholar
• MisawaFKishimotoTHagiKKaneJMCorrellCUSafety and tolerability of long-acting injectable versus oral antipsychotics: a meta-analysis of randomized controlled studies comparing the same antipsychoticsSchizophr Res20161762–322023027499361
   PubMed Web of Science ®Google Scholar
• OstuzziGBighelliISoRFurukawaTABarbuiCDoes formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studiesSchizophr Res2017183102127866695
   PubMed Web of Science ®Google Scholar
• TaipaleHMittendorfer-RutzEAlexandersonKAntipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophreniaSchizophr Res2018197274280
   PubMed Web of Science ®Google Scholar
• KimuraHKanaharaNSasakiTRisperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: results of a 2-year prospective study, including an additional 1-year follow-upJ Psychopharmacol201630879580227371496
   PubMed Web of Science ®Google Scholar
• HoriHKatsukiAAtakeKYoshimuraREffects of continuing oral risperidone vs. switching from risperidone to risperidone long-acting injection on cognitive function in stable schizophrenia patients: a pilot studyFront Psychiatry2018997429568276
   PubMed Web of Science ®Google Scholar
• NasrallahHAThe case for long-acting antipsychotic agents in the post-CATIE eraActa Psychiatr Scand2007115426026717355516
   PubMed Web of Science ®Google Scholar
• ChuePEerdekensMAugustynsIComparative efficacy and safety of long-acting risperidone and risperidone oral tabletsEur Neuropsychopharmacol200515111111715572280
   PubMed Web of Science ®Google Scholar
• BaiYMTing ChenTChenJYEquivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic studyJ Clin Psychiatry20076881218122517854246
   PubMed Web of Science ®Google Scholar
• MatsumotoTMiyawakiTUeHKandaTZenjiCMoritaniTAutonomic responsiveness to acute cold exposure in obese and non-obese young womenInt J Obes Relat Metab Disord199923879380010490779
   PubMed Web of Science ®Google Scholar
• MatsumotoTUshiroyamaTMorimuraMAutonomic nervous system activity in the late luteal phase of eumenorrheic women with premenstrual symptomatologyJ Psychosom Obstet Gynaecol200627313113917214447
   PubMed Web of Science ®Google Scholar
• MoritaniTKimuraTHamadaTNagaiNElectrophysiology and kinesiology for health and diseaseJ Electromyogr Kinesiol200515324025515763671
   PubMed Web of Science ®Google Scholar
• HattoriSKishidaISudaAEffects of four atypical antipsychotics on autonomic nervous system activity in schizophreniaSchizophr Res201819313413828709776
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashington DCAPA1994
   Google Scholar
• KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull19871322612763616518
   PubMed Web of Science ®Google Scholar
• InadaTInagakiAPsychotropic dose equivalence in JapanPsychiatry Clin Neurosci201569844044725601291
   PubMed Web of Science ®Google Scholar
• FujibayashiMMatsumotoTKishidaIAutonomic nervous system activity and psychiatric severity in schizophreniaPsychiatry Clin Neurosci200963453854519496998
   PubMed Web of Science ®Google Scholar
• KimuraTMatsumotoTAkiyoshiMBody fat and blood lipids in postmenopausal women are related to resting autonomic nervous system activityEur J Appl Physiol200697554254716779552
   PubMed Web of Science ®Google Scholar
• AkselrodSGordonDUbelFAShannonDCBergerACCohenRJPower spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular controlScience198121345042202226166045
   PubMed Web of Science ®Google Scholar
• PaganiMLombardiFGuzzettiSPower spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dogCirc Res19865921781932874900
   PubMed Web of Science ®Google Scholar
• PomeranzBMacaulayRJCaudillMAAssessment of autonomic function in humans by heart rate spectral analysisAm J Physiol Heart Circ Physiol19852481H151H153
   PubMed Web of Science ®Google Scholar
• RompelmanOCoenenAJKitneyRIMeasurement of heart-rate variability: part 1-comparative study of heart-rate variability analysis methodsMed Biol Eng Comput1977153233239195151
   PubMed Web of Science ®Google Scholar
• ChangHAChangCCTzengNSKuoTBLuRBHuangSYCardiac autonomic dysregulation in acute schizophreniaActa Neuropsychiatr201325315516425287469
   PubMed Web of Science ®Google Scholar
• JokinenVSyvänneMMäkikallioTHAiraksinenKEJHuikuriHVTemporal age-related changes in spectral, fractal and complexity characteristics of heart rate variabilityClin Physiol200121327328111380525
   PubMedGoogle Scholar
• GeertsHSpirosARobertsPAlphsLA quantitative systems pharmacology study on optimal scenarios for switching to paliperidone palmitate once-monthlySchizophr Res2018996417261268
   Web of Science ®Google Scholar
• SheehanJJReillyKRFuDJAlphsLComparison of the peak-to-trough fluctuation in plasma concentration of long-acting injectable antipsychotics and their oral equivalentsInnov Clin Neurosci201297–81723
   PubMedGoogle Scholar
• IyoMTadokoroSKanaharaNOptimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosisJ Clin Psychopharmacol201333339840423609386
   PubMed Web of Science ®Google Scholar
• KakiharaSYoshimuraRShinkaiKPrediction of response to risperidone treatment with respect to plasma concentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6Int Clin Psychopharmacol2005202717815729081
   PubMed Web of Science ®Google Scholar
• YoshimuraRUedaNNakamuraJPossible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptomsNeuropsychobiology200144312913311586052
   PubMed Web of Science ®Google Scholar
• ChungMSYangACLinYCAssociation of altered cardiac autonomic function with psychopathology and metabolic profiles in schizophreniaPsychiatry Res2013210371071523978730
   PubMed Web of Science ®Google Scholar
• MoonELeeS-HKimD-HHwangBComparative study of heart rate variability in patients with schizophrenia, bipolar disorder, post-traumatic stress disorder, or major depressive disorderClin Psychopharmacol Neurosci201311313714324465250
   PubMed Web of Science ®Google Scholar
• QuintanaDSWestlyeLTKaufmannTReduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controlsActa Psychiatr Scand20161331445226371411
   PubMed Web of Science ®Google Scholar